# [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

> **NCT04989959** · PHASE1 · RECRUITING · sponsor: **Orhan Kemal Oz** · enrollment: 35 (estimated)

## Conditions studied

- Renal Cell Carcinoma
- Clear Cell Renal Cell Carcinoma

## Interventions

- **DRUG:** [18F]PT2385
- **PROCEDURE:** Positron Emission Tomography/Computed Tomography
- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT04989959
- **Lead sponsor:** Orhan Kemal Oz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-18
- **Primary completion:** 2026-08-18
- **Final completion:** 2027-08-18
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989959, "[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04989959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*